Medical Cannabis as a treatment option
With the opioid crisis in full swing across the USA and a decades long history of a “Drug War”, the controversy over medical marijuana continues to be a topic of great debate in the legislatures and in the press. Trying to separate the facts from the myths can be very difficult. No doubt most of the people reading this have an opinion, whether the opinion is based on facts, experience or feelings (or all of the above) depends on the individual. I’d like to share some facts and perhaps debunk some myths surrounding medical marijuana. First, because marijuana remains on Schedule 1 of the US Federal DEA Drug Classifications, it has been extremely difficult to obtain authorization to study its effects (either beneficial or detrimental) as Schedule 1 assumes there is no known therapeutic use and that a high potential for abuse exists. Heroin is also on Schedule 1 as is LSD and psilocybin. With marijuana, this classification has had the unfortunate consequence of hindering good scientific study, so we must turn to international studies or observational studies for our data. It is fascinating to think that alcohol, which has a high potential for abuse, is potentially addictive and has no significant known therapeutic use is available without prescription to individuals over 21. There are approximately 88,000 deaths annually due to alcohol in the US. Moving away from that comparison we should also review statistics relating to the opioid crisis in the USA. There were approximately 72,000 deaths in 2017 from opioids in the US.
What do we know for certain about medical marijuana?
Studies published recently (1) indicate that opioid related deaths have declined approximately 25% in states having medical marijuana available, while overall prescription drug use for chronic conditions tends to decline in those states as well. While high THC containing strains may certainly impair cognitive and motor skills when one is “under the influence”, not all strains contain the same quantity of THC and other cannabinoids. Therefore the “high” associated with marijuana varies greatly depending upon the strain and formulation. Additional study on the multiple cannabinoids found in the marijuana plant may yield additional information regarding particular benefits. There are some basic science studies demonstrating anti-tumor activity of some of the cannabinoids against colon and prostate cancer. (2) (3) Usefulness in treating post-traumatic stress disorder (PTSD), chronic pain, anxiety, insomnia, epilepsy (particularly a form of childhood epilepsy) has been reported, and the plant has been a folk remedy for ages across the world. Studies looking at mortality related to cannabis use found an increased risk for motor vehicle crashes associated with cannabis use, and an increased risk for pediatric overdose hospitalizations in states where marijuana has been legalized, but no evidence for increased risk of mortality overall among users of cannabis.
What conditions do we treat with medical marijuana and how is it supplied or dosed?
Many conditions have been treated with medical marijuana, among the most common are cancer and cancer-treatment-related symptoms, HIV-AIDS, post-traumatic stress disorder, chronic pain disorders, epilepsy, Parkinson’s and other neuromuscular disorders, neuropathy, and glaucoma. Use of purified CBD to treat childhood seizures has yielded some encouraging results, although studies are ongoing. In the state of Florida, medical marijuana must be prescribed by a physician following an evaluation and examination. Licensed dispensaries may provide the medical marijuana to a registered individual based upon the doctor’s order. Not all cannabis products produce a “high” associated with marijuana, and the balance between CBD and various strains can be optimized for desired results. Working with a knowledgeable physician and dispensary can be helpful in that regard.
If you or a loved one is suffering from a chronic condition and have been unable to obtain relief, or only have been able to obtain relief with an opioid, then medical marijuana may be worth considering. Consultations are available at the Center for Compassionate Medicine, at 561-701-2841.
Visit our new web site at https://centerforcompassionatemedicine.com/
(1)Bachhuber, M.A., et al. “Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010.” JAMA Intern Med doi: 10.1001/jamainternmed.2014.4005. Published online August 25, 2014.
(2) Cannabinoid Receptor Agonist-induced Apoptosis of Human Prostate Cancer Cells LNCaP Proceeds through Sustained Activation of ERK1/2 Leading to G1 Cell Cycle Arrest*
(3) Greenhough, A. , Patsos, H. A., Williams, A. C. and Paraskeva, C. (2007), The cannabinoid δ9‐tetrahydrocannabinol inhibits RAS‐MAPK and PI3K‐AKT survival signalling and induces BAD‐mediated apoptosis in colorectal cancer cells. Int. J. Cancer, 121: 2172-2180. Doi:10.1002/ijc.22917
Linda Kiley, MD
Linda Kiley, MD
Dr. Kiley is a Board Certified subspecialist in Female Pelvic Medicine and Reconstructive Surgery, and is also Board Certified in general Obstetrics and Gynecology.